RxDoctor Payments Data

Zachery Weyandt, DPM

Podiatrist · Louisville, KYNPI 1174189369

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (41.7%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Stryker at 38.6% of the total. Reporting peaked in 2023 at $16,197 and has fallen 61.5% since, to $6,237 in 2025. Among podiatrist clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,913in general payments, 2019–2025

Across 328 payments — averaging $112.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$14K
  • Arthrex$11K
  • Alpha Orthopedic Systems$3K
  • Paragon 28, Inc.$2K
  • Kerecis Limited$862
  • Smith+Nephew$828
  • plus $5K from 32 others

What the payments were for

  • Grants$10,00027%
  • Travel & lodging$9,13525%
  • Food & beverage$15,37842%
  • Education$2,4007%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,913 in reported general payments places this provider in the 90th percentile of 54 podiatrist providers in Kentucky.

See all podiatrist providers in Kentucky

Medicare billing

Part B allowed, 2024
$153,672
Medicare patients
319
Services billed
1,864

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate28$401
Ketoconazole17$375
Meloxicam23$353
Gabapentin30$202
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$185
Triamcinolone Acetonide11$177
Cephalexin17$105
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$41
Tramadol Hcl12$12

Paid to pharmacies, not to this prescriber.

Other podiatrist in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →